Joseph Carleone - Apr 25, 2024 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Stock symbol
SXT
Transactions as of
Apr 25, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 12:07 PM
Previous filing
Apr 1, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXT Common Stock Award $0 +1.44K +7.91% $0.00 19.6K Apr 25, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SXT Deferred Stock 19.4K Apr 25, 2024 Common Stock 19.4K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
F2 Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F3 Deferred stock converts to common stock on a one-for-one basis.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.